BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14654523)

  • 21. Biology of osteogenic sarcoma.
    Wang LL
    Cancer J; 2005; 11(4):294-305. PubMed ID: 16197719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sarcoma in the young adult population: an international view.
    Soliman H; Ferrari A; Thomas D
    Semin Oncol; 2009 Jun; 36(3):227-36. PubMed ID: 19460580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting angiogenesis for the treatment of sarcoma.
    Balasubramanian L; Evens AM
    Curr Opin Oncol; 2006 Jul; 18(4):354-9. PubMed ID: 16721130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic relevance of increased angiogenesis in osteosarcoma.
    Kreuter M; Bieker R; Bielack SS; Auras T; Buerger H; Gosheger G; Jurgens H; Berdel WE; Mesters RM
    Clin Cancer Res; 2004 Dec; 10(24):8531-7. PubMed ID: 15623635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor: a therapeutic target for tumors of the Ewing's sarcoma family.
    Dalal S; Berry AM; Cullinane CJ; Mangham DC; Grimer R; Lewis IJ; Johnston C; Laurence V; Burchill SA
    Clin Cancer Res; 2005 Mar; 11(6):2364-78. PubMed ID: 15788688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telangiectatic osteosarcoma: the St. Jude Children's Research Hospital's experience.
    Weiss A; Khoury JD; Hoffer FA; Wu J; Billups CA; Heck RK; Quintana J; Poe D; Rao BN; Daw NC
    Cancer; 2007 Apr; 109(8):1627-37. PubMed ID: 17351949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue collection for correlative studies in childhood cancer clinical trials: ethical considerations and special imperatives.
    Anderson BD; Adamson PC; Weiner SL; McCabe MS; Smith MA
    J Clin Oncol; 2004 Dec; 22(23):4846-50. PubMed ID: 15570088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteosarcoma in patients older than 65 years.
    Longhi A; Errani C; Gonzales-Arabio D; Ferrari C; Mercuri M
    J Clin Oncol; 2008 Nov; 26(33):5368-73. PubMed ID: 18809616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future.
    Ludwig JA
    Curr Opin Oncol; 2008 Jul; 20(4):412-8. PubMed ID: 18525337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of major vault protein gene in osteosarcoma patients.
    Dalla-Torre CA; de Toledo SR; Yoshimoto M; Petrilli AS; Andrade JA; Chilton-MacNeill S; Squire JA; Zielenska M
    J Orthop Res; 2007 Jul; 25(7):958-63. PubMed ID: 17415755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of mitotic arrest and apoptosis by a novel synthetic quinolone analogue, CWC-8, via intrinsic and extrinsic apoptotic pathways in human osteogenic sarcoma U-2 OS cells.
    Chang YH; Yang JS; Kuo SC; Chung JG
    Anticancer Res; 2009 Aug; 29(8):3139-48. PubMed ID: 19661327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteosarcoma and Ewing's sarcoma in children and adolescents: retrospective clinicopathological study.
    Ilić I; Manojlović S; Cepulić M; Orlić D; Seiwerth S
    Croat Med J; 2004 Dec; 45(6):740-5. PubMed ID: 15578809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microtubule-targeting agents in angiogenesis: where do we stand?
    Pasquier E; Honoré S; Braguer D
    Drug Resist Updat; 2006; 9(1-2):74-86. PubMed ID: 16714139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma: results of a phase II study.
    Arpaci F; Ataergin S; Ozet A; Erler K; Basbozkurt M; Ozcan A; Komurcu S; Ozturk B; Celasun B; Kilic S; Kuzhan O
    Cancer; 2005 Sep; 104(5):1058-65. PubMed ID: 15999369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone tumors: osteosarcoma and Ewing's sarcoma.
    Heare T; Hensley MA; Dell'Orfano S
    Curr Opin Pediatr; 2009 Jun; 21(3):365-72. PubMed ID: 19421061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of osteogenic sarcoma in childhood].
    Horský I; Huraj E; Huraj E; Jindrová V; Paukovic I
    Acta Chir Orthop Traumatol Cech; 1984 Oct; 51(5):388-91. PubMed ID: 6595922
    [No Abstract]   [Full Text] [Related]  

  • 37. Transfer of complex frontline anticancer therapy to a developing country: the St. Jude osteosarcoma experience in Chile.
    Rivera GK; Quintana J; Villarroel M; Santana VM; Rodriguez-Galindo C; Neel MD; Velez G; Ribeiro RC; Daw NC
    Pediatr Blood Cancer; 2008 Jun; 50(6):1143-6. PubMed ID: 18085687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix metalloproteinases participate in osteosarcoma invasion.
    Bjørnland K; Flatmark K; Pettersen S; Aaasen AO; Fodstad O; Maelandsmo GM
    J Surg Res; 2005 Aug; 127(2):151-6. PubMed ID: 16083752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteosarcoma: current status of immunotherapy and future trends (Review).
    Mori K; Rédini F; Gouin F; Cherrier B; Heymann D
    Oncol Rep; 2006 Mar; 15(3):693-700. PubMed ID: 16465432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.